An interventional study of Community Champions and Homegrown Heroes in Type2diabetes, Heart Failure and Obesity, sponsored by Johns Hopkins University. Recruiting at 2 sites in United States. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Johns Hopkins University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Heart Failure by Johns Hopkins University — 6 open to participants now, 7 under way, none of them phase 3. Heart Failure · Johns Hopkins University.
Among the 21 studies in Heart Failure by Johns Hopkins University, this one is the 3rd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2025, is one of 6 with no phase, and was the 19th registered.
6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.
Browse Heart Failure studies →6 of the 21 studies in Heart Failure by Johns Hopkins University are open now, in 1 country. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 18–90
Johns Hopkins University · Sites in United States
Ages 21+ · Healthy volunteers
Johns Hopkins University · Sites in United States
Ages 18–85
Johns Hopkins University · Sites in United States
Ages 18+ · Healthy volunteers
Johns Hopkins University · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.
This study: 30 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 1 · Phase 4 2
First in 1988; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 156 is above the median of 76 across 4,053 interventional studies indexed under Heart Failure.
Median enrollment 29 across the 11 interventional studies, 132 across the 10 observational. Of the 14 that completed or were terminated, 6 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
Johns Hopkins University is the lead sponsor of 1,817 studies on the registry; 316 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
3 of the studies in Heart Failure by Johns Hopkins University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT00181259Johns Hopkins UniversityMagnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism | 2027-08 |
| NCT03775577Johns Hopkins UniversityExercise Intolerance in Heart Failure | 2027-08 |
| NCT06364644Johns Hopkins UniversityUnderstanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure | 2027-09 |
Add all 3 to your calendar (.ics) → With an account.
Among the 21 studies in Heart Failure by Johns Hopkins University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving outcomes for individuals with low socioeconomic status, type 2 diabetes, obesity, and early cardiac dysfunction than receiving education and access to a community exercise facility.
This randomized controlled trial employs a 2:1 allocation ratio. The study aims to include 156 individuals from Baltimore City and Hagerstown, Maryland, characterized by low neighborhood and individual socioeconomic status, type 2 diabetes, obesity, and evidence of subclinical heart dysfunction, without a prior clinical diagnosis of heart failure. The 6-month multi-level intervention consists of three key components:
Community Health Worker Support: Participants will receive ongoing support from community health workers as part of the intervention. These workers will conduct telephone and/or home visits at least monthly, offering assistance in following areas:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to the "Community Champions" group will undergo a six-month behavioral intervention. This intervention involves bi-weekly problem-solving training sessions (DECIDE) conducted in groups of 6-10 individuals, along with support from community health workers. Additionally, participants will receive a YMCA membership to exercise with a professional health coach.
Behavioral: Community Champions
Participants assigned to the "Homegrown Heroes" will receive a YMCA membership for exercise and a monthly newsletters for 6 months that include education about diabetes self-management, healthy lifestyle and heart failure prevention .
Behavioral: Homegrown Heroes
The UNLOAD-Heart Failure Program intervention includes problem solving training, community health worker support, and exercise support from health coaches at YMCAs.
Also known as: Multi-level intervention
Monthly newsletters/videos on diabetes self-management, healthy lifestyle and heart failure prevention will be provided, as well as a membership to the local YMCA.
Also known as: Education plus access to community exercise facility
Change in fitness as assessed by the 6 minute walk test
Total distance walked in the 6 minutes walk test in meters
Time frame: Baseline and 6 month follow up
Change in cardiac biomarker, high-sensitivity cardiac troponin-T (hs-cTnT)
Percent change from baseline in hs-cTnT
Time frame: Baseline and 6 month follow up
Change in hemoglobin A1c
Absolute change from baseline in hemoglobin A1c
Time frame: Baseline and 6 month follow up
Change in specific problem solving skills as assessed by Health Problem-Solving Scale (HPSS) subscales.
The following Health Problem-Solving Scale (HPSS) subscales will be assessed: Impulsive/Careless Problem Solving (IPS), Avoidant Problem Solving (APS), Negative Transfer (NTR), Negative Motivation/Orientation (NMO). Subscale scores are calculated by summing the scores for each item within the respective subscales. Higher subscale scores indicate more of that problem-solving characteristic. The score range for each subscale is as follows: IPS (0-32), APS (0-28), NTR (0-44), NMO (0-20). Total score range 0-124.
Time frame: Baseline, 6 month follow up, 12 month follow up
Changes in self care measures as assessed by Summary of Diabetes Self-Care Activities Scale (SDSCA)
The Summary of Diabetes Self-Care Activities Scale (SDSCA) is a tool used to measure diabetes self-care activities. 12-items with 5 sub-scales (diet, exercise, home blood glucose testing, foot care, smoking status). The respondent is asked how many days in the past week the behavior was performed (ranges from 0 to 7); The result is an average score between 0 and 7 with higher score indicating better diabetes self-management behavior.
Time frame: Baseline, 6 month follow up, 12 month follow up
Changes in disease knowledge as assessed by Diabetes and Cardiovascular Disease (CVD) Knowledge Test
The Diabetes and CVD Knowledge Test comprises 16 items, featuring both multiple-choice and true-or-false questions. This assessment tool gauges individuals' comprehension of diabetes, its impact on health, and optimal strategies for managing the condition. The possible score range is 0-17. A higher score indicates a better understanding of diabetes and cardiovascular disease.
Time frame: Baseline, 6 month follow up, 12 month follow up
Changes in physical activity as assessed by Modified Physical Activity Questionnaire (MPAQ)
The MPAQ is a tool used to estimate the frequency in days (number of times per month) and in time (minutes) someone participated in physical activity (e.g. biking, walking, swimming, etc.). Hours per week for all activities are summed to determine activity hours per week averaged over the past year. A higher sum indicates more physical activity. Values can also be weighted by their estimated metabolic cost and expressed as metabolic equivalent (MET) hours per week. Higher METs are associated with better outcomes. The MPAQ also assesses inactivity, such as the average number of hours per day spent watching television or being confined to a bed or chair for more than 1 week. A higher average indicates less physical activity.
Time frame: Baseline, 6 month follow up, 12 month follow up
Change in weight (kgs)
Change from baseline in weight (kgs)
Time frame: Baseline and 6 month follow-up
Change in BMI
Change from baseline in BMI (Kg/m\^2).
Time frame: Baseline and 6 month follow-up
Change in hip and waist circumference (centimeters)
Change from baseline in hip and waist circumference (centimeters)
Time frame: Baseline and 6 month follow up
Change in Metabolic Syndrome Severity Z score
Metabolic Syndrome Severity (MetS) Z score calculates an individual's metabolic syndrome severity score by examining five key markers: waist circumference, blood pressure, triglycerides, HDL, and fasting glucose. Score typically ranges from -5 to 5. Higher scores indicate greater metabolic syndrome severity.
Time frame: Baseline and 6 month follow up
Change in self-management as assessed by the Patient Activation Measure (PAM-13).
The Patient Activation Measure is a 13-item survey that will assess an individual's knowledge, skills and confidence to managing one's health and healthcare. The PAM scores is calculated and then transformed to a scale with a range from 0-100. A higher PAM score indicates higher patient activation. The score can also be converted into four activation levels: 1 - not believing activation important, 2 - lack of knowledge and confidence to take action, 3 - beginning to take action, 4 - taking action.
Time frame: Baseline, 6 month follow up,12 month follow up
Change in quality of life and overall health and well-being as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health 10
The PROMIS Global Health 10 survey comprises 10 items designed to evaluate both physical and mental health status. Scores are aggregated separately for physical and mental health, each ranging from 4 - 20. Higher scores in both categories indicate better outcomes.
Time frame: Baseline, 6 month follow up,12 month follow up
Change in blood pressure (systolic and diastolic (mmHg))
changes in blood pressure from baseline
Time frame: Baseline and 6 month follow up
Change in cardiac biomarker, gal-3
Percent change from baseline in gal-3
Time frame: Baseline and 6 month follow up
Change in cardiac biomarkers, NT-proBNP
Percent change from baseline in NT-proBNP
Time frame: Baseline and 6 month follow up
Change in post-walk Borg dyspnea scale
Changes in post-walk Borg dyspnea scale which ranges from 0 ("no shortness of breath") to 10 ("worst possible shortness of breath"); higher score worse breathing difficulty. Measured in a subset of the population.
Time frame: Baseline and 6 month follow up
Change in cardiorespiratory fitness as assessed by peak oxygen uptake (V02 peak)
Change in peak oxygen uptake (VO2 peak) as assessed by a cardiopulmonary fitness test in a subset of the population.
Time frame: Baseline and 6 month follow up
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Sep 2027, 27 months after the start.
Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 27 months is close to that.
Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 14, 2026: primary completion Sep 2026 → Sep 2027 and completion Mar 2027 → Sep 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.